No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business

Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.

Read more »

Immune-Based Treatments for Brain Cancer Post Impressive Early-Stage Results

Approximately 19,000 individuals in the US are diagnosed with primary brain cancers each year.

Read more » News Bytes: $DCTH, $TRA, $POT, $SUPG, $ACCP.OB, $AMLN

Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.

Read more »